CompletedNCT07093736
A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders
Device studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Atlanta and 1 more locationSee all locations and recruitment
Study information
Study start dateStarted: July 6, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 220
- Sponsor
- Fisher Wallace Laboratories
- Sponsor type
- Pharmaceutical company
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07093736
- Official title
Show the full official title
A Randomized Waitlist-controlled Trial to Evaluate of the Effectiveness of Immediate Treatment Compared to Deferred Treatment With the Fisher Wallace Stimulator FW-200 Device in First Responders With Self-reported Anxiety
Get this study by email
Recruitment & locations
CompletedAtlanta · Seattle
Questions about this study
Who is behind this study?
The study sponsor is Fisher Wallace Laboratories, a pharmaceutical company.
Who was this study for?
Listed age limits: from 18 years.
